VIM
VRTX icon

Vista Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Vista Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$736K Hold
1,649
– – 0.25% 104
2025
Q4 		$748K Buy
1,649
+1
+0.1% +$431 0.25% 100
2025
Q3 		$645K Buy
1,648
+34
+2% +$14.2K 0.23% 108
2025
Q2 		$719K Sell
1,614
-40
-2% -$18.4K 0.27% 103
2025
Q1 		$802K Sell
1,654
-18
-1% -$8.39K 0.31% 93
2024
Q4 		$673K Buy
1,672
+20
+1% +$9.27K 0.26% 104
2024
Q3 		$768K Sell
1,652
-20
-1% -$9.61K 0.29% 99
2024
Q2 		$784K Sell
1,672
-28
-2% -$12.2K 0.32% 91
2024
Q1 		$711K Sell
1,700
-53
-3% -$22.4K 0.29% 98
2023
Q4 		$713K Buy
1,753
+1
+0.1% +$369 0.33% 95
2023
Q3 		$609K Sell
1,752
-24
-1% -$8.39K 0.32% 99
2023
Q2 		$625K Sell
1,776
-110
-6% -$37.1K 0.32% 102
2023
Q1 		$594K Buy
1,886
+38
+2% +$11.4K 0.31% 101
2022
Q4 		$534K Sell
1,848
-9
-0.5% -$2.74K 0.3% 101
2022
Q3 		$538K Sell
1,857
-19
-1% -$5.47K 0.33% 95
2022
Q2 		$529K Sell
1,876
-22
-1% -$5.89K 0.32% 96
2022
Q1 		$495K Sell
1,898
-4
-0.2% -$949 0.27% 101
2021
Q4 		$418K Sell
1,902
-26
-1% -$5.06K 0.23% 107
2021
Q3 		$350K Buy
1,928
+271
+16% +$52.9K 0.21% 118
2021
Q2 		$334K Buy
+1,657
New +$347K 0.2% 124

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vista Investment Management's VRTX Position: Q1 2026 in Review

Vista Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 1,649 shares worth $736K. The position accounts for 0.25% of the portfolio, ranked #104.

Vista Investment Management first reported a position in VRTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $802K in Q1 2025. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Vista Investment Management held 1,649 shares of Vertex Pharmaceuticals worth $736K as of Q1 2026.
  • Vista Investment Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.25% of Vista Investment Management's portfolio in Q1 2026, its #104 holding.
  • Vista Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Vista Investment Management's Vertex Pharmaceuticals position peaked at $802K in Q1 2025.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Vista Investment Management's 13F filing for Q1 2026, filed 15 May 2026.